vs
Cincinnati Financial（CINF）与福泰制药（VRTX）财务数据对比。点击上方公司名可切换其他公司
福泰制药的季度营收约是Cincinnati Financial的1.1倍（$3.2B vs $2.8B），福泰制药净利率更高（37.3% vs 9.6%，领先27.8%），福泰制药同比增速更快（9.5% vs -1.7%），过去两年福泰制药的营收复合增速更高（8.9% vs 5.2%）
辛辛那提金融公司主营财产与意外伤害保险，通过旗下辛辛那提保险公司、辛辛那提赔偿公司及辛辛那提意外伤害保险公司运营核心业务。目前该公司在美国国内财险保费市场占比达1.01%，按市场份额计算位列美国第20大保险公司。
福泰制药是总部位于美国马萨诸塞州波士顿的生物制药企业，是全球首批明确采用理性药物设计策略、而非组合化学方法开发药物的生物技术公司之一。除波士顿总部外，公司还在加州圣迭戈、英国牛津郡米尔顿公园设有三处研发中心。
CINF vs VRTX — 直观对比
营收规模更大
VRTX
是对方的1.1倍
$2.8B
营收增速更快
VRTX
高出11.3%
-1.7%
净利率更高
VRTX
高出27.8%
9.6%
两年增速更快
VRTX
近两年复合增速
5.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8B | $3.2B |
| 净利润 | $274.0M | $1.2B |
| 毛利率 | — | 85.4% |
| 营业利润率 | — | 37.8% |
| 净利率 | 9.6% | 37.3% |
| 营收同比 | -1.7% | 9.5% |
| 净利润同比 | 404.4% | 30.5% |
| 每股收益（稀释后） | — | $4.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CINFVRTX
| Q1 26 | $2.8B | — | ||
| Q4 25 | $3.1B | $3.2B | ||
| Q3 25 | $3.7B | $3.1B | ||
| Q2 25 | $3.2B | $3.0B | ||
| Q1 25 | $2.6B | $2.8B | ||
| Q4 24 | $2.5B | $2.9B | ||
| Q3 24 | $3.3B | $2.8B | ||
| Q2 24 | $2.5B | $2.6B |
净利润CINFVRTX
| Q1 26 | $274.0M | — | ||
| Q4 25 | $676.0M | $1.2B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $685.0M | $1.0B | ||
| Q1 25 | $-90.0M | $646.3M | ||
| Q4 24 | $405.0M | $913.0M | ||
| Q3 24 | $820.0M | $1.0B | ||
| Q2 24 | $312.0M | $-3.6B |
毛利率CINFVRTX
| Q1 26 | — | — | ||
| Q4 25 | — | 85.4% | ||
| Q3 25 | — | 86.5% | ||
| Q2 25 | — | 86.3% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 85.5% | ||
| Q3 24 | — | 85.8% | ||
| Q2 24 | — | 85.9% |
营业利润率CINFVRTX
| Q1 26 | — | — | ||
| Q4 25 | 27.2% | 37.8% | ||
| Q3 25 | 37.9% | 38.6% | ||
| Q2 25 | 26.3% | 38.8% | ||
| Q1 25 | -5.0% | 22.7% | ||
| Q4 24 | 18.9% | 35.2% | ||
| Q3 24 | 31.3% | 40.3% | ||
| Q2 24 | 15.2% | -132.9% |
净利率CINFVRTX
| Q1 26 | 9.6% | — | ||
| Q4 25 | 21.9% | 37.3% | ||
| Q3 25 | 30.1% | 35.2% | ||
| Q2 25 | 21.1% | 34.8% | ||
| Q1 25 | -3.5% | 23.3% | ||
| Q4 24 | 16.0% | 31.4% | ||
| Q3 24 | 24.7% | 37.7% | ||
| Q2 24 | 12.3% | -135.8% |
每股收益（稀释后）CINFVRTX
| Q1 26 | — | — | ||
| Q4 25 | $4.29 | $4.64 | ||
| Q3 25 | $7.11 | $4.20 | ||
| Q2 25 | $4.34 | $3.99 | ||
| Q1 25 | $-0.57 | $2.49 | ||
| Q4 24 | $2.57 | $3.62 | ||
| Q3 24 | $5.20 | $4.01 | ||
| Q2 24 | $1.98 | $-13.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $6.6B |
| 总债务越低越好 | $816.0M | — |
| 股东权益账面价值 | $15.7B | $18.7B |
| 总资产 | $41.2B | $25.6B |
| 负债/权益比越低杠杆越低 | 0.05× | — |
8季度趋势，按日历期对齐
现金及短期投资CINFVRTX
| Q1 26 | $1.2B | — | ||
| Q4 25 | $148.0M | $6.6B | ||
| Q3 25 | $1.6B | $6.3B | ||
| Q2 25 | $1.1B | $6.4B | ||
| Q1 25 | $1.1B | $6.2B | ||
| Q4 24 | $1.3B | $6.1B | ||
| Q3 24 | $1.8B | $6.5B | ||
| Q2 24 | $771.0M | $5.8B |
总债务CINFVRTX
| Q1 26 | $816.0M | — | ||
| Q4 25 | $861.0M | — | ||
| Q3 25 | $858.0M | — | ||
| Q2 25 | $859.0M | — | ||
| Q1 25 | $853.0M | — | ||
| Q4 24 | $850.0M | — | ||
| Q3 24 | $849.0M | — | ||
| Q2 24 | $849.0M | — |
股东权益CINFVRTX
| Q1 26 | $15.7B | — | ||
| Q4 25 | $15.9B | $18.7B | ||
| Q3 25 | $15.4B | $17.3B | ||
| Q2 25 | $14.3B | $17.2B | ||
| Q1 25 | $13.7B | $16.5B | ||
| Q4 24 | $13.9B | $16.4B | ||
| Q3 24 | $13.8B | $15.6B | ||
| Q2 24 | $12.8B | $14.8B |
总资产CINFVRTX
| Q1 26 | $41.2B | — | ||
| Q4 25 | $41.0B | $25.6B | ||
| Q3 25 | $40.6B | $24.9B | ||
| Q2 25 | $38.8B | $24.0B | ||
| Q1 25 | $37.3B | $22.9B | ||
| Q4 24 | $36.5B | $22.5B | ||
| Q3 24 | $37.0B | $22.2B | ||
| Q2 24 | $34.8B | $20.1B |
负债/权益比CINFVRTX
| Q1 26 | 0.05× | — | ||
| Q4 25 | 0.05× | — | ||
| Q3 25 | 0.06× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 0.06× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $498.0M |
| 自由现金流经营现金流 - 资本支出 | — | $348.6M |
| 自由现金流率自由现金流/营收 | — | 10.9% |
| 资本支出强度资本支出/营收 | — | 4.7% |
| 现金转化率经营现金流/净利润 | — | 0.42× |
| 过去12个月自由现金流最近4个季度 | — | $3.2B |
8季度趋势，按日历期对齐
经营现金流CINFVRTX
| Q1 26 | — | — | ||
| Q4 25 | $947.0M | $498.0M | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $741.0M | $1.1B | ||
| Q1 25 | $310.0M | $818.9M | ||
| Q4 24 | $642.0M | $584.6M | ||
| Q3 24 | $912.0M | $1.4B | ||
| Q2 24 | $742.0M | $-3.8B |
自由现金流CINFVRTX
| Q1 26 | — | — | ||
| Q4 25 | $939.0M | $348.6M | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $737.0M | $927.4M | ||
| Q1 25 | $307.0M | $778.2M | ||
| Q4 24 | $638.0M | $492.0M | ||
| Q3 24 | $906.0M | $1.3B | ||
| Q2 24 | $737.0M | $-3.8B |
自由现金流率CINFVRTX
| Q1 26 | — | — | ||
| Q4 25 | 30.4% | 10.9% | ||
| Q3 25 | 29.8% | 37.0% | ||
| Q2 25 | 22.7% | 31.3% | ||
| Q1 25 | 12.0% | 28.1% | ||
| Q4 24 | 25.1% | 16.9% | ||
| Q3 24 | 27.3% | 47.0% | ||
| Q2 24 | 29.0% | -144.5% |
资本支出强度CINFVRTX
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 4.7% | ||
| Q3 25 | 0.1% | 3.3% | ||
| Q2 25 | 0.1% | 4.9% | ||
| Q1 25 | 0.1% | 1.5% | ||
| Q4 24 | 0.2% | 3.2% | ||
| Q3 24 | 0.2% | 2.4% | ||
| Q2 24 | 0.2% | 2.6% |
现金转化率CINFVRTX
| Q1 26 | — | — | ||
| Q4 25 | 1.40× | 0.42× | ||
| Q3 25 | 0.99× | 1.15× | ||
| Q2 25 | 1.08× | 1.04× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | 1.59× | 0.64× | ||
| Q3 24 | 1.11× | 1.31× | ||
| Q2 24 | 2.38× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CINF
| Property casualty | $2.6B | 93% |
| Life | $105.0M | 4% |
| Other | $92.0M | 3% |
| Fee revenues | $1.0M | 0% |
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |
